Wayne Smith

Wayne Smith

Auto-generated profile, based on publicly available information

Wayne Smith

Hypertension in Africa Research Team (HART), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2010 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
BSBalindiwe Sishi
Balindiwe Sishi
BLBenjamin Loos
Benjamin Loos
BEBeverly Ellis
Beverly Ellis
WSWayne Smith
Wayne Smith
ETEugene F. du Toit
Eugene F. du Toit
Anna-Mart EngelbrechtAnna-Mart Engelbrecht
Anna-Mart Engelbrecht

23 July 2012 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
Aletta SchutteAletta Schutte
Aletta Schutte
RSRudolph Schutte
Rudolph Schutte
HHHugo W Huisman
Hugo W Huisman
JRJohannes M van Rooyen
Johannes M van Rooyen
CFCarla Mt Fourie
Carla Mt Fourie
AKAnnamarie Kruger
Annamarie Kruger
Background Longitudinal cohort studies in sub-Saharan Africa are urgently needed to understand cardiovascular disease development. We, therefore, explored health behaviours and conventional risk factors of African individuals with optimal blood pressure (BP) (≤120/80 mm Hg), and their 5-year prediction for the development of hypertension. Methods The Prospective Urban Rural Epidemiology study in the North West Province, South Africa, started in 2005 and included African volunteers (n = 1994; aged > 30 years) from a sample of 6000 randomly selected households in rural and urban areas. Results At baseline, 48% of the participants were hypertensive (≥140/90 mmHg). Those with optimal BP (n = 478) were followed at a success rate of 70% for 5 years (213 normotensive, 68 hypertensive, 57 deceased). Africans that became hypertensive smoked more than the normotensive individuals (68.2% vs 49.8%), and they also had a greater waist circumference [ratio of geometric means of 0.94 cm (95% CI: 0.86–0.99)] and greater amount of γ-glutamyltransferase [0.74 U/l (95% CI: 0.62–0.88)] at baseline. The 5-year change in BP was independently explained by baseline γ-glutamyltransferase [R2 = 0.23, β = 0.13 U/l (95% CI: 0.01–0.19)]. Alcohol intake also predicted central systolic BP and carotid cross-sectional wall area (CSWA) at follow-up. Waist circumference was another predictor of BP changes [β = 0.18 cm (95% CI: 0.05–0.24)] and CSWA. HIV infection was inversely associated with increased BP. Conclusions During the 5 years, 24% of Africans with optimal BP developed hypertension. The surge in hypertension in Africa is largely explained by modifiable risk factors. Public health strategies should focus aggressively on lifestyle to prevent a catastrophic burden on the national health system.

6 January 2019 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
Aletta SchutteAletta Schutte
Aletta Schutte
PGPhilimon N Gona
Philimon N Gona
CDChristian Delles
Christian Delles
AUAletta S Uys
Aletta S Uys
ABAdele Burger
Adele Burger
HHHugo W Huisman
Hugo W Huisman
Globally hypertension is stabilising, but in sub-Saharan Africa the incidence of hypertension remains on an increase. Although this might be attributed to poor healthcare and ineffective antihypertensive treatment, there is a limited understanding of population and individual-specific cardiovascular pathophysiology – necessary for effective prevention and treatment strategies in Africa. As there is a lack of longitudinal studies tracking the early pathophysiological development of hypertension in black populations, the African-PREDICT study was initiated. The purpose of this paper is to describe the detailed methodology and baseline cohort profile of the study. From 2013 to 2017, the study included 1202 black (N = 606) and white (N = 596) men and women (aged 20–30 years) from South Africa – screened to be healthy and clinic normotensive. At baseline, and each 5-year follow-up examination, detailed measures of health behaviours, cardiovascular profile and organ damage are taken. Also, comprehensive biological sampling for the ‘omics’ and biomarkers is performed. Overall, the baseline black and white cohort presented with similar ages, clinic and 24-hour blood pressures, but black adults had lower socioeconomic status and higher central systolic blood pressure than white individuals. The prospective African-PREDICT study in young black and white adults will contribute to a clear understanding of early cardiovascular disease development.

1 May 2015 in Atherosclerosis
Verified
Journal Article
Closed access
CFC.M.T. Fourie
C.M.T. Fourie
Aletta SchutteAletta Schutte
Aletta Schutte
WSW. Smith
W. Smith
AKA. Kruger
A. Kruger
JRJ.M. van Rooyen
J.M. van Rooyen

23 March 2017 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
Aletta SchutteAletta Schutte
Aletta Schutte
SBS Botha
S Botha
CFC M T Fourie
C M T Fourie
Lebo Francina Gafane-MatemaneLebo Francina Gafane-Matemane
Lebo Francina Gafane-Matemane
Ruan KrugerRuan Kruger
Ruan Kruger
HHH W Huisman
H W Huisman

1 February 2016 in EBioMedicine
Verified
Journal Article
Open access
FWFang-Fei Wei
Fang-Fei Wei
NDNadja E.A. Drummen
Nadja E.A. Drummen
Aletta SchutteAletta Schutte
Aletta Schutte
LTLutgarde Thijs
Lutgarde Thijs
LJLotte Jacobs
Lotte Jacobs
JSJan Albert Staessen
Jan Albert Staessen
Following activation by vitamin K (VK), matrix Gla protein (MGP) inhibits arterial calcification, but its role in preserving renal function remains unknown. In 1166 white Flemish (mean age, 38.2 years) and 714 South Africans (49.2% black; 40.6 years), we correlated estimated glomerular filtration (eGFR [CKD-EPI formula]) and stage of chronic kidney disease (CKD [KDOQI stages 2-3]) with inactive desphospho-uncarboxylated MGP (dp-ucMGP), using multivariable linear and logistic regression. Among Flemish and white and black Africans, between-group differences in eGFR (90, 100 and 122 mL/min/1.73 m(2)), dp-ucMGP (3.7, 6.5 and 3.2 μg/L), and CKD prevalence (53.5, 28.7 and 10.5%) were significant, but associations of eGFR with dp-ucMGP did not differ among ethnicities (P ≥ 0.075). For a doubling of dp-ucMGP, eGFR decreased by 1.5 (P = 0.023), 1.0 (P = 0.56), 2.8 (P = 0.0012) and 2.1 (P < 0.0001) mL/min/1.73 m(2) in Flemish, white Africans, black Africans and all participants combined; the odds ratios for moving up one CKD stage were 1.17 (P = 0.033), 1.03 (P = 0.87), 1.29 (P = 0.12) and 1.17 (P = 0.011), respectively. In the general population, eGFR decreases and CKD risk increases with higher dp-ucMGP, a marker of VK deficiency. These findings highlight the possibility that VK supplementation might promote renal health.